reports
- Baptiste Salaville
- Bruno Cavalier
- Martin Marandon-Carlhian
- Sinan Doganli
SGO COMPAGNIE DE SAINT-GOBAIN SA
MC LVMH MOET HENNESSY LOUIS VUITTON SE
UHR SWATCH GROUP LTD. BEARER
RMS HERMES INTERNATIONAL SCA
EXE EXEL INDUSTRIES SA
EL ESSILORLUXOTTICA SA
BRBY BURBERRY GROUP PLC
KER KERING SA
01913 PRADA S.P.A.
MONC MONCLER SPA
BC BRUNELLO CUCINELLI S.P.A.
CFR COMPAGNIE FINANCIERE RICHEMONT SA
DKG DEUTSCHE KONSUM REIT-AG
SAE SHOP APOTHEKE EUROPE NV
AG1 AUTO1 GROUP
ORP ORPEA
HAVAS HAVAS N.V
CAN CANAL+
- Baptiste Salaville
- Bruno Cavalier
- Martin Marandon-Carlhian
- Sinan Doganli
SGO COMPAGNIE DE SAINT-GOBAIN SA
MC LVMH MOET HENNESSY LOUIS VUITTON SE
UHR SWATCH GROUP LTD. BEARER
RMS HERMES INTERNATIONAL SCA
EXE EXEL INDUSTRIES SA
EL ESSILORLUXOTTICA SA
BRBY BURBERRY GROUP PLC
KER KERING SA
01913 PRADA S.P.A.
MONC MONCLER SPA
BC BRUNELLO CUCINELLI S.P.A.
CFR COMPAGNIE FINANCIERE RICHEMONT SA
DKG DEUTSCHE KONSUM REIT-AG
SAE SHOP APOTHEKE EUROPE NV
AG1 AUTO1 GROUP
ORP ORPEA
HAVAS HAVAS N.V
CAN CANAL+
- Sinan Doganli
- Juan Ros-Padilla
- Thomas Zlowodzki
ODDO BHF Small & MIDCAP MORNING NEWS - 11/05/2024
European equity markets weakened in October following multiple disappointments across the earnings season. The impending US election, the outcome of which is highly uncertain according to the polls, may also have prompted some traders to adopt a cautious stance. Sovereign long rates rose sharply, particularly in the US, on the back of macro indicators likely to provide arguments to the most hawkish of central bankers. All eyes are now on the November 5 elections and their repercussion...
VCT VICAT-CIMENTS VICAT SA
LEI LEIFHEIT AG
SZG SALZGITTER AG
ALDEL DELFINGEN INDUSTRY SA
ISS ISS A/S
NOEJ NORMA GROUP SE
MBB MBB INDUSTRIES SE
G24 SCOUT24 AG
COR CORTICEIRA AMORIM SGPS SA
TUB TUBACEX S.A.
BCHN BURCKHARDT COMPRESSION HOLDING AG
PSG PROSEGUR COMPANIA DE SEGURIDAD SA
SAE SHOP APOTHEKE EUROPE NV
SAB BANCO DE SABADELL SA
S30 SOLUTIONS 30 SE
EXN EXCLUSIVE NETWORKS SA
SHUR SHURGARD SELF STORAGE LIMITED
- Juan Ros-Padilla
- Thomas Zlowodzki
ISS A/S : Growing visibility on short- to medium-term triggers leads t...
Les marchés actions européens ont fléchi en octobre après les nombreuses déceptions sur la saison des résultats. L’approche de l’élection US, très incertaine selon les sondages, pourrait également avoir poussé à la prudence certains opérateurs. Les taux longs souverains ont nettement remonté, en particulier aux Etats-Unis, sur la base d’indicateurs macro susceptibles de donner des arguments aux plus faucons des banquiers centraux. Tous les yeux sont désormais rivés sur le scrutin du 5...
VCT VICAT-CIMENTS VICAT SA
LEI LEIFHEIT AG
SZG SALZGITTER AG
ALDEL DELFINGEN INDUSTRY SA
ISS ISS A/S
NOEJ NORMA GROUP SE
MBB MBB INDUSTRIES SE
G24 SCOUT24 AG
COR CORTICEIRA AMORIM SGPS SA
TUB TUBACEX S.A.
BCHN BURCKHARDT COMPRESSION HOLDING AG
PSG PROSEGUR COMPANIA DE SEGURIDAD SA
SAE SHOP APOTHEKE EUROPE NV
SAB BANCO DE SABADELL SA
S30 SOLUTIONS 30 SE
EXN EXCLUSIVE NETWORKS SA
SHUR SHURGARD SELF STORAGE LIMITED
- Sinan Doganli
Redcare Pharmacy : Lower adjusted EBITDA margin as Redcare invests in ...
>Double-digit top-line growth in Q3 - Q3 results on the top line are in line with the trading update that was released at the beginning of October. Total revenue increased by +20.9% y-o-y to € 575.0m. Revenue in the DACH region increased by +20.3% y-o-y to € 469.0m and in international markets by +22.4% y-o-y to € 105.0m. Adjusted EBITDA came in at € 11.4m, a decline of -25.0% y-o-y and -12.3% below consensus expectations. However, despite adjusted EBITDA coming in be...
EQS-News: Redcare Pharmacy: Starkes Wachstum im dritten Quartal bei ei...
EQS-News: Redcare Pharmacy N.V. / Schlagwort(e): 9-Monatszahlen/Zwischenbericht Redcare Pharmacy: Starkes Wachstum im dritten Quartal bei einer bereinigten EBITDA-Marge von 2%. Rx-Momentum in Deutschland mit einem Umsatzplus von über 130% weiter beschleunigt. 05.11.2024 / 06:30 CET/CEST Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. Redcare Pharmacy: Starkes Wachstum im dritten Quartal bei einer bereinigten EBITDA-Marge von 2%. Rx-Momentum in Deutschland mit einem Umsatzplus von über 130% weiter beschleunigt. Konzernumsatz wächst im dritten ...
EQS-News: Redcare Pharmacy: strong Q3 growth combined with 2% adj. EBI...
EQS-News: Redcare Pharmacy N.V. / Key word(s): 9 Month figures/Interim Report Redcare Pharmacy: strong Q3 growth combined with 2% adj. EBITDA margin. Rx momentum in Germany further increased, with sales growth of over 130% in October. 05.11.2024 / 06:30 CET/CEST The issuer is solely responsible for the content of this announcement. Redcare Pharmacy: strong Q3 growth combined with 2% adj. EBITDA margin. Rx momentum in Germany further increased, with sales growth of over 130% in October. Total Group sales growth 21% in Q3 to EUR 575M and 34% year to date to EUR 1.7bn after...
- Ahmed Ben Salem
- Ahmed Ben Salem
- Sinan Doganli
Redcare Pharmacy : Redcare sees opportunities to capitalise on strong ...
>E-Rx sales above consensus estimates - Redcare Pharmacy reported significant growth in Germany's prescription (Rx) segment in Q3 2024 which grew at +81% y-o-y to € 69.0m, some +8.8% above consensus expectations. Growth in German Rx sales even reached 108% in September. Based on these strong e-prescription (E-Rx) indicators, the company sees opportunities to further capitalise on demand for e-Rx and plans to boost marketing efforts in Q4. As a result, the company ha...
EQS-News: Redcare Pharmacy achieves 81% growth in Q3 Rx sales in Germa...
EQS-News: Redcare Pharmacy N.V. / Key word(s): Change in Forecast/Preliminary Results Redcare Pharmacy achieves 81% growth in Q3 Rx sales in Germany, 108% in September and decides to accelerate marketing based on very convincing e-Rx metrics. 03.10.2024 / 22:01 CET/CEST The issuer is solely responsible for the content of this announcement. Redcare Pharmacy achieves 81% growth in Q3 Rx sales in Germany, 108% in September and decides to accelerate marketing based on very convincing e-Rx metrics. Q3 total Group sales up 21% year over year to EUR 574M and year to date 34% to...
EQS-News: Redcare Pharmacy verzeichnet in Deutschland im dritten Quart...
EQS-News: Redcare Pharmacy N.V. / Schlagwort(e): Prognoseänderung/Vorläufiges Ergebnis Redcare Pharmacy verzeichnet in Deutschland im dritten Quartal 81% Rx-Wachstum, im September sogar 108% und beschließt auf Basis überzeugender E-Rx-Kennzahlen, Marketingaktivitäten zu intensivieren 03.10.2024 / 22:01 CET/CEST Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. Redcare Pharmacy verzeichnet in Deutschland im dritten Quartal 81% Rx-Wachstum, im September sogar 108% und beschließt auf Basis überzeugender E-Rx-Kennzahlen, ihre Marketingaktivitäten zu...
- Michael B. Schäfer
- Sinan Doganli
- Thomas Zlowodzki
ODDO BHF Small & MIDCAP MORNING NEWS - 07/30/2024
With regard to our list of recommended stocks, i) we are adding: adidas, Merck KGaA, Santander, Technip FMC, Unilever and Vivendi , ii) we are maintaining ASMi, Atlas Copco, AXA, Deutsche Boerse, GSK, Holcim, Inditex, Lonza, Sodexo, RELX and Rolls-Royce, iii) we are removing: BASF, Nemetschek, Nestlé and TUI AG. - ...
- Michael B. Schäfer
- Sinan Doganli
- Thomas Zlowodzki
ODDO BHF Small & MIDCAP MORNING NEWS - 30/07/2024
Au sein de notre liste de valeurs recommandées, i) nous faisons entrer : adidas, Merck KGaA, Santander, Technip FMC, Unilever et Vivendi, ii) nous maintenons ASMi, Atlas Copco, Axa, Deutsche Boerse, GSK, Holicm, Inditex, Lonza, Sodexo, RELX et Rolls-Royce, iii) nous faisons sortir : BASF, Nemetschek, Nestlé, TUI AG. - ...
NK IMERYS SA
ALDEL DELFINGEN INDUSTRY SA
EKI EKINOPS SA
MRN MERSEN SA
EBRO EBRO FOODS SA
COR CORTICEIRA AMORIM SGPS SA
IDR INDRA SISTEMAS S.A. CLASS A
SAE SHOP APOTHEKE EUROPE NV
DUFN DUFRY AG
GEST GESTAMP AUTOMOCION S.A.
THEP THERMADOR HOLDING SA
FPE3 FUCHS PETROLUB SE
ALLFG ALLFUNDS (UK) LTD
- Andreas Riemann
- Sinan Doganli
Redcare Pharmacy : Final Q2 2024 results in line with expectations
>Adj. EBITDA rises +12.8% y-o-y on the back of solid top-line growth - This morning Redcare Pharmacy released its final Q2 results that were overall in line with our and the consensus expectations. Earlier this month, Redcare already pre-released sales numbers of € 560m (+33% y-o-y), which were in line with expectations. Group sales were driven by an increase of +21% y-o-y in non-Rx sales to € 390m and an increase of +75% y-o-y of Rx sales to € 170m. Adj. EBITDA incr...
EQS-News: Redcare Pharmacy achieves rapid increase of Rx sales in Germ...
EQS-News: Redcare Pharmacy N.V. / Key word(s): Half Year Results/Half Year Report Redcare Pharmacy achieves rapid increase of Rx sales in Germany, continues its strong double-digit overall growth rate and closes Q2 with a solid 2.7% margin. 30.07.2024 / 06:30 CET/CEST The issuer is solely responsible for the content of this announcement. Redcare Pharmacy achieves rapid increase of Rx sales in Germany, continues its strong double-digit overall growth rate and closes Q2 with a solid 2.7% margin. Total sales of over EUR 1.1 bn after six months, up 42%, with Q2 year-over-y...
EQS-News: Redcare Pharmacy: Starkes Rx-Umsatzplus in Deutschland bei a...
EQS-News: Redcare Pharmacy N.V. / Schlagwort(e): Halbjahresergebnis/Halbjahresbericht Redcare Pharmacy: Starkes Rx-Umsatzplus in Deutschland bei anhaltend hohem zweistelligen Gesamtwachstum mit einer soliden Marge von 2,7 Prozent im zweiten Quartal. 30.07.2024 / 06:30 CET/CEST Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. Redcare Pharmacy: Starkes Rx-Umsatzplus in Deutschland bei anhaltend hohem zweistelligen Gesamtwachstum mit einer soliden Marge von 2,7 Prozent im zweiten Quartal. Konzernumsatz nach sechs Monaten bei über EUR 1,1 Mrd., ei...
- Ahmed Ben Salem
- Marc Lavaud
- Thijs Berkelder
FP TOTAL SE
EQNR EQUINOR ASA
GALP GALP ENERGIA SGPS SA CLASS B
SLB.N SCHLUMBERGER NV
GTT GAZTRANSPORT & TECHNIGAZ SA
SBMO SBM OFFSHORE NV
EURN EURONAV NV
PGS PGS ASA
BOSS HUGO BOSS AG
ENI ENI S.P.A.
NEX NEXANS SA
ERA ERAMET SA
P2F PETROFAC LIMITED
REP REPSOL SA
SOC SUBSEA 7 S.A.
SBO SCHOELLER-BLECKMANN OILFIELD EQUIPMENT AG
TRE TECNICAS REUNIDAS SA
DR0 DEUTSCHE ROHSTOFF AG
TEC TECHNIPFMC PLC
SAE SHOP APOTHEKE EUROPE NV
BP. BP P.L.C.
CGG CGG
ENOG ENERGEAN PLC
VK VALLOUREC SA
TE TECHNIP ENERGIES NV
FUR FUGRO NV
SHEL SHELL PLC
SPM SAIPEM S.P.A.
TEN TENARIS S.A.
PLX PLUXEE NV
- Ahmed Ben Salem
- Bruno Cavalier
- Marc Lavaud
- Thijs Berkelder
FP TOTAL SE
EQNR EQUINOR ASA
GALP GALP ENERGIA SGPS SA CLASS B
SLB.N SCHLUMBERGER NV
GTT GAZTRANSPORT & TECHNIGAZ SA
SBMO SBM OFFSHORE NV
EURN EURONAV NV
PGS PGS ASA
BOSS HUGO BOSS AG
ENI ENI S.P.A.
NEX NEXANS SA
ERA ERAMET SA
P2F PETROFAC LIMITED
REP REPSOL SA
SOC SUBSEA 7 S.A.
SBO SCHOELLER-BLECKMANN OILFIELD EQUIPMENT AG
TRE TECNICAS REUNIDAS SA
DR0 DEUTSCHE ROHSTOFF AG
TEC TECHNIPFMC PLC
SAE SHOP APOTHEKE EUROPE NV
BP. BP P.L.C.
CGG CGG
ENOG ENERGEAN PLC
VK VALLOUREC SA
TE TECHNIP ENERGIES NV
FUR FUGRO NV
SHEL SHELL PLC
SPM SAIPEM S.P.A.
TEN TENARIS S.A.
PLX PLUXEE NV
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.